New study reveals higher mortality risk in COVID-19 patients with newly-diagnosed atrial fibrillation

The incidence and prognosis of newly diagnosed AF in patients hospitalized due to SARS-CoV-2.

Super Bowl parade shooting survivors await promised donations while bills pile up

Abigail Arellano keeps her son Samuel’s medical bills in a blue folder in a cabinet above the microwave. Even now, four months after the 11-year-old

June 21, 2024

FDA fast tracks Quince Therapeutics’ rare ataxia drug EryDex – Pharmaceutical Technology

The FDA has granted fast track designation to Quince Therapeutics’ Phase III drug candidate EryDex to treat rare disease ataxia-telangiectasia. Credit: grandbrothers via Shutterstock. California-based

June 4, 2024

Filament Health Completes the First Export of Botanical Psilocybin to Australia | Psychedelic Invest

Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) (“Filament” or the “Company”), a clinical‐stage natural psychedelic drug development company, today announced that it

January 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.